TSH BIOPHARM CORPORATION LIMITED

Press Releases TSH Biopharm Corporation Limited

Equities

8432

TW0008432006

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
60.3 ^TWD	+2.20%		+10.24%	+19.88%

Mar. 11	TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024	CI
Mar. 11	TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TSH Biopharm : is invited to attend the online institutional investor conference hosted by IBF Securities	22-08-09	PU
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022	22-08-04	PU
TSH Biopharm : Announcement of setting up the Sustainable Development Committee and members of TSH's first Sustainable Development Committee	22-08-04	PU
TSH Biopharm : was invited to attend the online institutional investor conference hosted by Concord Securities	22-05-24	PU
TSH Biopharm : Announcement of Change to Remuneration Committee member	22-05-24	PU
TSH Biopharm : Announcement of Change to Audit Committee member	22-05-24	PU
TSH Biopharm : Announcement of the Company’s list of newly elected independent director	22-05-24	PU
TSH Biopharm : Announcement of the Ex-dividend Record Date of Cash Dividends	22-05-24	PU
TSH Biopharm : Important resolutions of the Company's 2022 General Shareholders' Meeting	22-05-24	PU
TSH Biopharm : Resignation of the vice general manager of General Administration Division, spokesperson and corporate governance officer of the Company	22-04-29	PU
TSH Biopharm : was invited to attend the online institutional investor conference hosted by E.Sun Securities	22-03-04	PU
TSH Biopharm : Board of Directors resolved to convene the 2022 Annual General Shareholders' Meeting	22-03-04	PU
TSH Biopharm : Board of Directors' Resolution on Distribution of 2021 Earnings	22-03-04	PU
TSH Biopharm : Board of Directors Approved Financial Statements For the Year Ended December 31, 2021	22-03-04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer